Company / AR per Share
Akebia Therapeutics, Inc. AR per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.21
FY2025
5-year range
$0.18 / $0.34
FY2021-FY2025
Trend
+18.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share returned to growth in FY2025 after 3 years of decline, reaching $0.21.
Based on SEC 10-K filings.
0.21 in FY2025 with a 5-year CAGR of -1.1%.
Remained stable around $0.21 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- -2.8%
- 5-Year CAGR
- -1.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, ar per share increased 18.4% year-over-year.
- Peak ar per share was recorded in FY2018.
- Lowest ar per share in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | +18.4% |
| FY2024 | $0.18 | -17.2% |
| FY2023 | $0.21 | -6.2% |
| FY2022 | $0.23 | -33.8% |
| FY2021 | $0.34 | +55.7% |
| FY2020 | $0.22 | -33.6% |
| FY2019 | $0.33 | -5.0% |
| FY2018 | $0.35 | - |
| FY2015 | - | - |
| FY2014 | $0.03 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026